Could Spinach Help Treat Dry Eye Disease? A New Scientific Approach

Dry eye disease is a common and often persistent condition that affects more than a billion people worldwide, causing stinging, soreness, and inflammation. Recently, researchers at the National University of Singapore (NUS) have explored an innovative way to address this discomfort: by borrowing photosynthetic machinery from spinach leaves to create light-powered eye drops.

This experimental technology, recently described in scientific reports, aims to use the eye’s natural exposure to light to trigger therapeutic effects within the ocular tissue. By adapting plant-based processes for mammalian cells, researchers hope to offer a new strategy for managing ocular surface inflammation.

How the Technology Works

Plants generate energy through photosynthesis, a process conducted by organelles known as chloroplasts. Within these structures, specific components called thylakoids—which contain chlorophyll—carry out the light-dependent reactions that produce chemical energy.

The research team, led by biomolecular engineer Xing Kuoran at NUS, extracted these thylakoid membrane stacks from spinach leaves. They encapsulated these stacks to create a system they named LEAF, which stands for “light-reaction enriched thylakoid NADPH-foundry.”

When these nanoparticles are applied to eye cells, they function as a biological “battery.” Upon exposure to ambient light, the system produces NADPH, a molecule that helps cells combat reactive oxygen species—compounds that drive inflammation and cellular stress in conditions like dry eye disease. By neutralizing these harmful molecules, the treatment aims to reduce inflammation and support tissue repair.

Promising Results in Lab Models

In initial studies using lab-grown human eye cells and mice engineered to simulate dry eye disease, the LEAF system demonstrated a significant ability to mitigate inflammation. The researchers observed that the light-powered treatment helped restore tear production and reduced damage to the cornea.

According to the research team, the concentration of chlorophyll used in the drops is kept low to ensure the solution remains transparent, meaning patients would not experience green-tinted vision. The therapy is designed to work using the light that naturally enters the eye, aligning the treatment with the organ’s normal physiological environment.

Key Takeaways

• Nature-Inspired Engineering: The treatment uses thylakoid stacks from spinach to turn light into chemical energy within the eye.
• Targeting Inflammation: The system produces NADPH, an antioxidant that helps neutralize the inflammatory compounds associated with dry eye disease.
• Light-Activated: The therapy is designed to be activated by ambient light, making it a potentially convenient, non-invasive option.
• Early Development: While the results in animal models are encouraging, the technology is still in the early stages of development and is not yet available for human use.

Looking Toward the Future

While the prospect of “photosynthetic” eye drops is an exciting development, the technology is not yet ready for clinical practice. Extensive testing is still required to confirm the long-term safety and efficacy of the treatment in humans. The research team is currently working toward establishing clinical trials to further evaluate the potential of this light-powered approach.

If successful, this method could represent a significant shift in how we approach ocular health, moving beyond traditional lubricants to strategies that actively support the metabolic needs of eye tissue using the light we see every day.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare professional regarding any eye conditions or treatment options.